Download PDF

Other users also viewed these articles

Efficacy, persistence and optimization of ustekinumab in ulcerative colitis: Clinical practice data Irene Latras-Cortés; Patricia Suárez Álvarez; María García Prada; Noelia Cano Sanz; Luis Vaquero Ayala; Mónica Sierra-Ausín;
Gastroenterol Hepatol. 2023;46:377-9
Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection Alejandro Hernández Camba; Laura Ramos; María Blanca Madrid Álvarez; Lina Pérez-Méndez; Pilar Nos; Vicent Hernández; Ivan Guerra; Nuria Jiménez; Rufo Lorente; Mónica Sierra-Ausín; Daniel Ginard; Pilar Varela Trastoy; Laura Arranz; María José Cabello Tapia; Yamile Zabana; Manuel Barreiro-de Acosta;
Gastroenterol Hepatol. 2022;45:668-76
Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies Xavier Calvet; Daniel Carpio; Iago Rodríguez-Lago; Rosario García-Vicuña; Manuel Barreiro-de-Acosta; Xavier Juanola; Mariam Aguas; Concepción Castillo; Jordi Gratacós;
Gastroenterol Hepatol. 2021;44:587-98